Skip to main content

Table 1 The effect of RARW consumption on biometric measurements in rats

From: Chronic and moderate consumption of reduced-alcohol wine confers cardiac benefits in a rat model of pulmonary arterial hypertension

 

C

MCT

RARW

MCT + RARW

Body mass (g)

311.9 ± 21.6

292.6 ± 4.2

291.0 ± 16.3

283.9 ± 12.6

Whole heart mass (g)

1.59 ± 0.11

1.65 ± 0.08

1.44 ± 0.07

1.47 ± 0.10

RV mass (g)

0.23 ± 0.03

0.39 ± 0.03*

0.23 ± 0.04

0.29 ± 0.04

Liver mass (g)

18.18 ± 1.30

17.29 ± 0.51

17.49 ± 0.62

17.13 ± 0.89

Tibia length (cm)

4.80 ± 0.20

4.81 ± 0.07

5.02 ± 0.02

4.64 ± 0.12

LV + septal mass (g)

0.93 ± 0.04

0.86 ± 0.03

0.91 ± 0.03

0.89 ± 0.06

(LV + septal mass)/heart mass (g/g)

0.59 ± 0.02

0.52 ± 0.01*

0.64 ± 0.02

0.61 ± 0.02

Heart mass/tibia length (g/cm)

0.33 ± 0.03

0.34 ± 0.02

0.29 ± 0.01

0.32 ± 0.02

RV/(LV + septal mass) (g/g)

0.24 ± 0.03

0.45 ± 0.02*

0.25 ± 0.03

0.32 ± 0.03

RV/tibia length (g/cm)

0.047 ± 0.007

0.081 ± 0.006*

0.045 ± 0.007

0.063 ± 0.008

Heart mass/body mass (g/g)

0.0052 ± 0.0008

0.0057 ± 0.0003

0.0050 ± 0.0002

0.0052 ± 0.0004

Liver mass/body mass (g/g)

0.061 ± 0.009

0.059 ± 0.002

0.060 ± 0.002

0.060 ± 0.001

  1. Rats consumed wine for 7 days before and 28 days after being injected with PAH-inducing MCT
  2. Values are means ± S.E.M
  3. C Control, MCT monocrotaline, RARW reduced-alcohol red wine, RV right ventricular, LV left ventricular
  4. *p < 0.05 (vs C); p < 0.05 (vs MCT); n ≥ 5 per group